Clinical Trial Update: Fulvestrant in Treating Patients With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating fulvestrant for advanced prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Fulvestrant (Faslodex) (fulvestrant)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED